drugset

drugset / Trial / NCT00302133

Optimizing Pharmacotherapy for Bipolar Alcoholics

NCT00302133 ↗

Phase 1/2 Completed 88 enrolled University of Miami

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test the efficacy of naltrexone and valproate in the treatment of comorbid bipolar disorder and alcohol dependence.

Timeline

Start: 2006-05
Primary completion: 2013-04
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Naltrexone	Small molecule	50 mg	Oral

Indications